Celiac Disease and Inflammatory Bowel Disease

Our comprehensive testing for celiac disease and inflammatory bowel disease evaluates patients suspected of having celiac disease, including patients with compatible symptoms, patients with atypical symptoms, and individuals at increased risk. We also offer a variety of interactive, step-by-step algorithms that provide the most appropriate selection of tests for each patient, while maintaining the highest possible sensitivity and specificity.

 

Celiac Update

The National Institute of Health (NIH) has reported that as many as 1% (3,000,000) of all Americans have celiac disease and hundreds of thousands of these patients are undiagnosed.  In 2006, the NIH launched an aggressive campaign to heighten physician awareness of the disease.  With new diagnostic guidelines and new tests available, this effort should significantly reduce the time to diagnosis, which currently averages 10 years from the onset of symptoms.

 

New Standards and New Tests

Laboratory algorithms using a reflex approach provide an alternative to ordering individual tests when evaluating a patient with suspected celiac disease.  The goal of algorithms is to provide the most appropriate selection of tests for each patient, while maintaining the highest possible sensitivity and specificity.

Click the link below for more information on these tests.

mayocliniclabs

Mayo Medical Laboratories

This post was authored by the Marketing Team at Mayo Medical Laboratories.